Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 3
2017 4
2018 2
2019 2
2020 1
2021 4
2022 9
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of tofacitinib for treatment of alopecia areata in children: A systematic review and meta-analysis.
Behrangi E, Barough MS, Khoramdad M, Hejazi P, Koltapeh MP, Goodarzi A. Behrangi E, et al. J Cosmet Dermatol. 2022 Dec;21(12):6644-6652. doi: 10.1111/jocd.15425. Epub 2022 Oct 24. J Cosmet Dermatol. 2022. PMID: 36177815 Review.
BACKGROUND: Tofacitinib, a potent JAK inhibitor, has gained increasing interest, in recent years, among dermatologists for the management of refractory alopecia areata. ...Few side effects such as diarrhea and mild liver transaminases abnormalities were noted in sev …
BACKGROUND: Tofacitinib, a potent JAK inhibitor, has gained increasing interest, in recent years, among dermatologists for the manage …
Oral tofacitinib for the treatment of alopecia areata in pediatric patients.
Kibbie J, Kines K, Norris D, Dunnick CA. Kibbie J, et al. Pediatr Dermatol. 2022 Jan;39(1):31-34. doi: 10.1111/pde.14855. Epub 2021 Nov 14. Pediatr Dermatol. 2022. PMID: 34779041
BACKGROUND: Alopecia areata (AA) is characterized by the loss of hair, often in well-demarcated areas. ...However, few studies have examined the clinical efficacy and tolerability of oral tofacitinib in the treatment of pediatric AA. OBJECTIVE: To summarize t …
BACKGROUND: Alopecia areata (AA) is characterized by the loss of hair, often in well-demarcated areas. ...However, few studies have e …
An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review.
Brown L, Skopit S. Brown L, et al. J Drugs Dermatol. 2018 Aug 1;17(8):914-917. J Drugs Dermatol. 2018. PMID: 30124734 Review.
Unfortunately, patient was lost to follow-up after the discontinuation of treatment. From previous case reports we can postulate that his alopecia returned to baseline after discontinuation of tofacitinib. ...This is the youngest patient ever reported to be successf …
Unfortunately, patient was lost to follow-up after the discontinuation of treatment. From previous case reports we can postulate that his …
Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib-A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata.
Kołcz K, Żychowska M, Sawińska E, Reich A. Kołcz K, et al. Dermatol Ther (Heidelb). 2023 Mar;13(3):843-856. doi: 10.1007/s13555-023-00889-0. Epub 2023 Jan 13. Dermatol Ther (Heidelb). 2023. PMID: 36639612 Free PMC article.
Alopecia areata (AA) is a cell-mediated autoimmune disease in which a cytotoxic T-cell response against hair follicles occurs. ...So far, topical tofacitinib and ruxolitinib, as well as systemic tofacitinib, ruxolitinib, and baricitinib have been used off-lab …
Alopecia areata (AA) is a cell-mediated autoimmune disease in which a cytotoxic T-cell response against hair follicles occurs. ...So …
Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review.
Huang J, Li T, Tan Z, Tang Y, Li J, Liu F, Shi W. Huang J, et al. Acta Derm Venereol. 2023 Sep 20;103:adv13418. doi: 10.2340/actadv.v103.13418. Acta Derm Venereol. 2023. PMID: 37731213 Free PMC article. Review.
Alopecia areata (AA) is a common cause of hair loss in children. Despite numerous therapeutic options for paediatric AA, none have been found to be both effective and safe. Recent studies have demonstrated the efficacy and safety of the Janus kinase (JAK) inhibitor …
Alopecia areata (AA) is a common cause of hair loss in children. Despite numerous therapeutic options for paediatric AA, none …
Treatments for alopecia areata: a network meta-analysis.
Mateos-Haro M, Novoa-Candia M, Sánchez Vanegas G, Correa-Pérez A, Gaetano Gil A, Fernández-García S, Ortega-Quijano D, Urueña Rodriguez MG, Saceda-Corralo D, Bennouna-Dalero T, Giraldo L, Tomlinson J, Vaño-Galván S, Zamora J. Mateos-Haro M, et al. Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013719. doi: 10.1002/14651858.CD013719.pub2. Cochrane Database Syst Rev. 2023. PMID: 37870096 Review.
BACKGROUND: Alopecia areata is an autoimmune disease leading to nonscarring hair loss on the scalp or body. ...OBJECTIVES: To assess the benefits and harms of the treatments for alopecia areata (AA), alopecia totalis (AT), and alopecia universalis (AU) …
BACKGROUND: Alopecia areata is an autoimmune disease leading to nonscarring hair loss on the scalp or body. ...OBJECTIVES: To assess …
27 results